ATE142268T1 - Retroviraler vektor - Google Patents

Retroviraler vektor

Info

Publication number
ATE142268T1
ATE142268T1 AT89906574T AT89906574T ATE142268T1 AT E142268 T1 ATE142268 T1 AT E142268T1 AT 89906574 T AT89906574 T AT 89906574T AT 89906574 T AT89906574 T AT 89906574T AT E142268 T1 ATE142268 T1 AT E142268T1
Authority
AT
Austria
Prior art keywords
transcription unit
introducing
sequence
retroviral vector
dna encoding
Prior art date
Application number
AT89906574T
Other languages
English (en)
Inventor
Eli Gilboa
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22726179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE142268(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE142268T1 publication Critical patent/ATE142268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89906574T 1988-05-17 1989-05-17 Retroviraler vektor ATE142268T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19662888A 1988-05-17 1988-05-17

Publications (1)

Publication Number Publication Date
ATE142268T1 true ATE142268T1 (de) 1996-09-15

Family

ID=22726179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906574T ATE142268T1 (de) 1988-05-17 1989-05-17 Retroviraler vektor

Country Status (8)

Country Link
EP (1) EP0371119B1 (de)
JP (1) JPH02504344A (de)
AT (1) ATE142268T1 (de)
AU (1) AU631554B2 (de)
CA (1) CA1335798C (de)
DE (1) DE68927089T2 (de)
DK (1) DK13290A (de)
WO (1) WO1989011539A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
GB8901778D0 (en) * 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US6251675B1 (en) 1989-05-25 2001-06-26 Duke University Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication
US5871958A (en) * 1989-05-25 1999-02-16 Duke University Mutant rev genes encoding transdominant repressors of HIV replication
GB2269175A (en) * 1992-07-31 1994-02-02 Imperial College Retroviral vectors
CA2154363A1 (en) * 1993-01-22 1994-08-04 Bruce A. Sullenger Localization of therapeutic agents
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
CA2168202A1 (en) * 1993-07-30 1995-03-16 Joseph Dougherty Efficient gene transfer into primary lymphocytes
US5902880A (en) * 1994-08-19 1999-05-11 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
US6146886A (en) 1994-08-19 2000-11-14 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
EE03492B1 (et) 1994-09-02 2001-08-15 GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid
FR2727429B1 (fr) 1994-11-30 1997-11-28 Haguenauer Odile Cohen Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
DE69627644T2 (de) 1995-03-09 2004-02-19 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
DE69633180D1 (de) 1995-06-27 2004-09-23 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
AU713382B2 (en) 1996-03-27 1999-12-02 Bavarian Nordic A/S Cytochrome P450 transducing retroviral vectors
AU2419599A (en) * 1998-01-06 1999-07-26 Bavarian Nordic Research Institute A/S Reconstituting retroviral vector (recon vector) for targeted gene expression

Also Published As

Publication number Publication date
WO1989011539A1 (en) 1989-11-30
EP0371119A4 (en) 1990-12-05
DE68927089D1 (de) 1996-10-10
AU631554B2 (en) 1992-12-03
EP0371119B1 (de) 1996-09-04
DK13290A (da) 1990-03-16
JPH02504344A (ja) 1990-12-13
DK13290D0 (da) 1990-01-16
CA1335798C (en) 1995-06-06
AU3740489A (en) 1989-12-12
EP0371119A1 (de) 1990-06-06
DE68927089T2 (de) 1997-04-03

Similar Documents

Publication Publication Date Title
DE68927089D1 (de) Retroviraler vektor
NO992464L (no) FremgangsmÕte for fremstilling av rekombinante viruser
DE68924775D1 (de) Verwendungen viraler enzyme.
EP0305929A3 (de) Membranen mit gebundenen Oligonukleotiden oder Peptiden
ES2098120T3 (es) Procedimiento para la obtencion de 3,4-epoxi en 1-buteno.
FI944136A0 (fi) Koostumuksia ja menetelmä sialyylitransferaasien identifioimiseksi ja syntesoimiseksi
BR8704419A (pt) Cartucho de gas co2 pressurizado e processo de preparacao domestica de bebidas carbonatadas
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
NO20003400L (no) Borevæske med invertert emulsjon, inneholdende blandinger av sekundære estere fremstilt ved omdannelse av olefiner, og fremgangsmÕte for fremstilling av slike blandinger
DE3873342D1 (de) Nicht-zylindrischer reaktor zur herstellung von furnace-russ.
NO166394C (no) Fremgangsmaate for oksydering i gassfase, samt reaktor foranvendelse ved fremgangsmaaten.
DE3784237D1 (de) Partiell oxydation von kohlenwasserstoffgasen.
NO873809D0 (no) Skip med en i skipets akterstevn anordnet propell, samt fremgangsmaate ved skipets drift.
DE3781564D1 (de) Verfahren zur herstellung von bromierten pyrrolo-(3,4-c)-pyrrolen.
ES2021031B3 (es) Compuesto de dioxazina que tiene un grupo reactivo tipo fibra de vinilsulfona.
Gilad et al. Measurement of the 16O (pi+, pi 0p) reaction
IL65597A (en) Preparation of 1alpha,24,25-trihydroxy-and 24,25-dihydroxy-cholesterol and certain novel intermediates used therein
DE68922507D1 (de) Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden.
DE69510146D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorethan
NO874574D0 (no) Fremgangsmaate for fremstilling av styrenert hydrokinon.
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
DE69105166D1 (de) Verfahren zur Herstellung von 1,1,1,2-tetraflourethan.
DE68914324D1 (de) Verfahren zur Oxydation von Kohlenwasserstoffen unter Verwendung von Verteilung des oxydierenden Gases.
DE3674964D1 (de) Herstellung von faserverstaerkten verbundstoffen.
NO900709L (no) Fremgangsmaate for destruering av hypoklorit i en kloratopploesning.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee